SpringWorks Therapeutics
SWTX
SWTX was delisted on the 30th of June, 2025.
78 hedge funds and large institutions have $1.46B invested in SpringWorks Therapeutics in 2020 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 41 increasing their positions, 12 reducing their positions, and 7 closing their positions.
242% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 12
143% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 7
64% more capital invested
Capital invested by funds: $895M → $1.46B (+$569M)
13% more funds holding
Funds holding: 69 → 78 (+9)
4.09% more ownership
Funds ownership: 76.84% → 80.93% (+4.1%)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$19.6M |
| 2 |
DM
Deerfield Management
New York
|
+$15.9M |
| 3 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$15.3M |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$14.7M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$9.12M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$17.1M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$11M |
| 3 |
Jennison Associates
New York
|
-$6.85M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.6M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$5.4M |
SWTX Hedge Fund Activity: Q2 2020 in Review
78 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in SpringWorks Therapeutics (SWTX) for Q2 2020, worth a combined $1.46B — up 64% from $895M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new SWTX positions and 7 closed out — a net gain of 10 holders — while 41 added to existing stakes and 12 trimmed.
The largest buyer was BlackRock, adding an estimated $19.6M. The largest seller was BVF Inc, cutting an estimated $17.1M.
- 78 institutional investors held SpringWorks Therapeutics (SWTX) as of Q2 2020, up from 69 in Q1 2020.
- Funds reported $1.46B of SpringWorks Therapeutics stock for Q2 2020, up 64% quarter-over-quarter.
- 17 funds opened new SpringWorks Therapeutics positions in Q2 2020 and 7 closed out, a net change of +10 holders.
- The largest SpringWorks Therapeutics buyer in Q2 2020 was BlackRock, an estimated $19.6M added.
- The largest SpringWorks Therapeutics seller in Q2 2020 was BVF Inc, an estimated $17.1M sold.
Based on aggregated 13F filings for Q2 2020.